PortViewPortView
GlucoTrack logo

GlucoTrack (GCTK) Stock Analysis

NASDAQHealthcareMedical - Devices

$3.87+5.16%
1-year price historyRange $3.68 – $158.85
52-week range$3.87
$3.49$212.10

What GlucoTrack does

GlucoTrack, Inc. is a medical device company that focuses on the design, development, and commercialization of novel technologies for people with diabetes. The company is developing the GlucoTrack CBGM, a long-term implantable continuous blood glucose monitoring system for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients.

Key metrics

Market cap
$3.09M
P/E (TTM)
-0.19
EPS (TTM)
$-20.89
Beta
0.66
Dividend yield
0.00%
Revenue / share
$0.00
50-day avg
$5.71
200-day avg
$26.77
52-week high
$212.10
52-week low
$3.49
CEO
Erik Emerson

ETFs linked to GCTK

Broad-market and Healthcare sector ETFs an investor holding GlucoTrack is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how GCTK fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze GCTK in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for GlucoTrack?
GlucoTrack trades under the ticker GCTK on NASDAQ.
Which exchange is GCTK listed on?
GCTK is listed on NASDAQ.
What sector does GlucoTrack operate in?
GlucoTrack is classified in the Healthcare sector (Medical - Devices industry).
How can PortView help analyze GCTK in a portfolio?
PortView shows GCTK's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.